Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study.
Saved in:
| Title: | Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study. |
|---|---|
| Authors: | Lozano-Tovar, Susana (AUTHOR), Cremascoli, Riccardo (AUTHOR), Nuccetelli, Marzia (AUTHOR), Sancesario, Giuseppe (AUTHOR), Cattaldo, Stefania (AUTHOR), Prina, Elisa (AUTHOR), Verde, Federico (AUTHOR), Cappelli, Simone (AUTHOR), Bernardini, Sergio (AUTHOR), Mercuri, Nicola Biagio (AUTHOR), Liguori, Claudio (AUTHOR) |
| Source: | Neurological Sciences. Aug2025, Vol. 46 Issue 8, p3631-3638. 8p. |
| Subjects: | Alzheimer's disease, Neurobehavioral disorders, Frontotemporal dementia, Sleep-wake cycle, Idiopathic diseases |
| Abstract: | In the present study, we investigated the differences in cerebrospinal fluid (CSF) orexin-A levels among patients with different neurocognitive disorders, such as mild or moderate to severe Alzheimer's disease (AD; mAD, msAD, respectively), behavioral variants of frontotemporal dementia (bv-FTD), non-fluent primary aphasia (NFPA), and idiopathic normal pressure hydrocephalus (iNPH). A total of 214 participants were evaluated (mAD, 45; msAD, 31; bv-FTD, 12; NFPA, 22; iNPH, 13; non-demented elderly controls, 91). The highest CSF orexin-A levels were found in iNPH patients (263.31 ± 56.89 pg/mL). Patients affected by NFPA (210.86 ± 61.99 pg/mL), iNPH, and msAD (173.04 ± 19.76 pg/mL) showed higher CSF orexin-A concentrations than controls (145.18 ± 27.01pg/mL) (p < 0.001). Bv-FTD (190.12 ± 100.84 pg/mL) and mAD (130.76 ± 21.70 pg/mL) patients showed no significant differences in CSF orexin-A levels compared with controls. mAD patients showed also lower CSF orexin-A concentrations than all other patient groups. In conclusion, orexin-A presents different CSF levels among neurocognitive disorders. The mechanisms underlying this difference vary and may include sleep-wake cycle impairment, behavioral disturbances, and CSF dynamics. The development of drugs that antagonize the orexin system could open a new frontier of research linking orexin neurotransmission to neurocognitive disorders. [ABSTRACT FROM AUTHOR] |
| Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 186678221 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lozano-Tovar%2C+Susana%22">Lozano-Tovar, Susana</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cremascoli%2C+Riccardo%22">Cremascoli, Riccardo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nuccetelli%2C+Marzia%22">Nuccetelli, Marzia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sancesario%2C+Giuseppe%22">Sancesario, Giuseppe</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cattaldo%2C+Stefania%22">Cattaldo, Stefania</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prina%2C+Elisa%22">Prina, Elisa</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verde%2C+Federico%22">Verde, Federico</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cappelli%2C+Simone%22">Cappelli, Simone</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bernardini%2C+Sergio%22">Bernardini, Sergio</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mercuri%2C+Nicola+Biagio%22">Mercuri, Nicola Biagio</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liguori%2C+Claudio%22">Liguori, Claudio</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Aug2025, Vol. 46 Issue 8, p3631-3638. 8p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Alzheimer's+disease%22">Alzheimer's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Neurobehavioral+disorders%22">Neurobehavioral disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Frontotemporal+dementia%22">Frontotemporal dementia</searchLink><br /><searchLink fieldCode="DE" term="%22Sleep-wake+cycle%22">Sleep-wake cycle</searchLink><br /><searchLink fieldCode="DE" term="%22Idiopathic+diseases%22">Idiopathic diseases</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: In the present study, we investigated the differences in cerebrospinal fluid (CSF) orexin-A levels among patients with different neurocognitive disorders, such as mild or moderate to severe Alzheimer's disease (AD; mAD, msAD, respectively), behavioral variants of frontotemporal dementia (bv-FTD), non-fluent primary aphasia (NFPA), and idiopathic normal pressure hydrocephalus (iNPH). A total of 214 participants were evaluated (mAD, 45; msAD, 31; bv-FTD, 12; NFPA, 22; iNPH, 13; non-demented elderly controls, 91). The highest CSF orexin-A levels were found in iNPH patients (263.31 ± 56.89 pg/mL). Patients affected by NFPA (210.86 ± 61.99 pg/mL), iNPH, and msAD (173.04 ± 19.76 pg/mL) showed higher CSF orexin-A concentrations than controls (145.18 ± 27.01pg/mL) (p < 0.001). Bv-FTD (190.12 ± 100.84 pg/mL) and mAD (130.76 ± 21.70 pg/mL) patients showed no significant differences in CSF orexin-A levels compared with controls. mAD patients showed also lower CSF orexin-A concentrations than all other patient groups. In conclusion, orexin-A presents different CSF levels among neurocognitive disorders. The mechanisms underlying this difference vary and may include sleep-wake cycle impairment, behavioral disturbances, and CSF dynamics. The development of drugs that antagonize the orexin system could open a new frontier of research linking orexin neurotransmission to neurocognitive disorders. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=186678221 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10072-025-08148-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 3631 Subjects: – SubjectFull: Alzheimer's disease Type: general – SubjectFull: Neurobehavioral disorders Type: general – SubjectFull: Frontotemporal dementia Type: general – SubjectFull: Sleep-wake cycle Type: general – SubjectFull: Idiopathic diseases Type: general Titles: – TitleFull: Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lozano-Tovar, Susana – PersonEntity: Name: NameFull: Cremascoli, Riccardo – PersonEntity: Name: NameFull: Nuccetelli, Marzia – PersonEntity: Name: NameFull: Sancesario, Giuseppe – PersonEntity: Name: NameFull: Cattaldo, Stefania – PersonEntity: Name: NameFull: Prina, Elisa – PersonEntity: Name: NameFull: Verde, Federico – PersonEntity: Name: NameFull: Cappelli, Simone – PersonEntity: Name: NameFull: Bernardini, Sergio – PersonEntity: Name: NameFull: Mercuri, Nicola Biagio – PersonEntity: Name: NameFull: Liguori, Claudio IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 15901874 Numbering: – Type: volume Value: 46 – Type: issue Value: 8 Titles: – TitleFull: Neurological Sciences Type: main |
| ResultId | 1 |